<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8520012</identifier>
<setSpec>1022-5129</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Merino Ugarte, C</dc:author>
<dc:description xml:lang="en">Identification of so called endothelium derived relaxing factor, EDRF, as nitric oxide, ON, produced in situ in digestive tract, as well as in many other organs, offers the possibility of pharmacologic control blocking or stimulating its production in situ. Theoretically, conditions like achalasia, cell injury by endotoxins, altered visceral arterial flow, hyperdynamic circulatory state in decompensated cirrhosis, protein synthesis and glomerular filtration in ascites, will be amenable of better treatment. This gas is considered as labile humoral-like messenger, mediator or a regulator of cell function in a number of physiological are promising. By now most of the information available comes from animal studies.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>1995 </dc:date>
<dc:title xml:lang="es">Oxido nítrico en gastroenterología.</dc:title>
<dc:title xml:lang="en">[Nitric oxide in gastroenterology].</dc:title>
<dc:publisher>Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru</dc:publisher>
</metadata>
</record>
</pubmed-document>
